Molecular map of liver disease could transform how disease is diagnosed and monitored

A survey led by researchers astatine Open Targets, EMBL's European Bioinformatics Institute (EMBL-EBI), the University of Cambridge and others has identified a acceptable of plasma proteins that could beryllium utilized to diagnose and show patients with metabolic dysfunction-associated steatotic liver illness (MASLD). It was published contiguous successful Nature Metabolism.